EconomyUS cobblers benefit as Ozempic users tighten their belts

US consumers taking weight-loss drugs such as Ozempic and Mounjaro are turning to cobblers and tailors to save money as they shed pounds. Rising out-of-pocket costs, partly driven by employers dropping GLP-1 coverage, are helping fuel the shift.